Literature DB >> 26278419

The Effect of Contact Precautions on Frequency of Hospital Adverse Events.

Lindsay D Croft1, Michael Liquori2, James Ladd1, Hannah Day1, Lisa Pineles1, Elizabeth Lamos2, Ryan Arnold2, Preeti Mehrotra3, Jeffrey C Fink1, Patricia Langenberg1, Linda Simoni-Wastila4, Eli Perencevich5, Anthony D Harris1, Daniel J Morgan1.   

Abstract

OBJECTIVE: To determine whether use of contact precautions on hospital ward patients is associated with patient adverse events
DESIGN: Individually matched prospective cohort study
SETTING: The University of Maryland Medical Center, a tertiary care hospital in Baltimore, Maryland
METHODS: A total of 296 medical or surgical inpatients admitted to non-intensive care unit hospital wards were enrolled at admission from January to November 2010. Patients on contact precautions were individually matched by hospital unit after an initial 3-day length of stay to patients not on contact precautions. Adverse events were detected by physician chart review and categorized as noninfectious, preventable and severe noninfectious, and infectious adverse events during the patient's stay using the standardized Institute for Healthcare Improvement's Global Trigger Tool.
RESULTS: The cohort of 148 patients on contact precautions at admission was matched with a cohort of 148 patients not on contact precautions. Of the total 296 subjects, 104 (35.1%) experienced at least 1 adverse event during their hospital stay. Contact precautions were associated with fewer noninfectious adverse events (rate ratio [RtR], 0.70; 95% confidence interval [CI], 0.51-0.95; P=.02) and although not statistically significant, with fewer severe adverse events (RtR, 0.69; 95% CI, 0.46-1.03; P=.07). Preventable adverse events did not significantly differ between patients on contact precautions and patients not on contact precautions (RtR, 0.85; 95% CI, 0.59-1.24; P=.41).
CONCLUSIONS: Hospital ward patients on contact precautions were less likely to experience noninfectious adverse events during their hospital stay than patients not on contact precautions.

Entities:  

Mesh:

Year:  2015        PMID: 26278419      PMCID: PMC4686266          DOI: 10.1017/ice.2015.192

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  21 in total

1.  Adverse effects of contact isolation.

Authors:  K B Kirkland; J M Weinstein
Journal:  Lancet       Date:  1999-10-02       Impact factor: 79.321

2.  Measuring hospital adverse events: assessing inter-rater reliability and trigger performance of the Global Trigger Tool.

Authors:  James M Naessens; Thomas J O'Byrne; Matthew G Johnson; Monica B Vansuch; Corey M McGlone; Jeanne M Huddleston
Journal:  Int J Qual Health Care       Date:  2010-06-09       Impact factor: 2.038

3.  Impact of contact isolation for multidrug-resistant organisms on the occurrence of medical errors and adverse events.

Authors:  J R Zahar; M Garrouste-Orgeas; A Vesin; C Schwebel; A Bonadona; F Philippart; C Ara-Somohano; B Misset; J F Timsit
Journal:  Intensive Care Med       Date:  2013-08-31       Impact factor: 17.440

4.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

5.  Carriage of methicillin-resistant Staphylococcus aureus, ceftazidime-resistant Gram-negative bacilli, and vancomycin-resistant enterococci before and after intensive care unit admission.

Authors:  Pak-Leung Ho
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

6.  The Critical Care Safety Study: The incidence and nature of adverse events and serious medical errors in intensive care.

Authors:  Jeffrey M Rothschild; Christopher P Landrigan; John W Cronin; Rainu Kaushal; Steven W Lockley; Elisabeth Burdick; Peter H Stone; Craig M Lilly; Joel T Katz; Charles A Czeisler; David W Bates
Journal:  Crit Care Med       Date:  2005-08       Impact factor: 7.598

7.  Universal glove and gown use and acquisition of antibiotic-resistant bacteria in the ICU: a randomized trial.

Authors:  Anthony D Harris; Lisa Pineles; Beverly Belton; J Kristie Johnson; Michelle Shardell; Mark Loeb; Robin Newhouse; Louise Dembry; Barbara Braun; Eli N Perencevich; Kendall K Hall; Daniel J Morgan; Syed K Shahryar; Connie S Price; Joseph J Gadbaw; Marci Drees; Daniel H Kett; L Silvia Muñoz-Price; Jesse T Jacob; Loreen A Herwaldt; Carol A Sulis; Deborah S Yokoe; Lisa Maragakis; Matthew E Lissauer; Marcus J Zervos; David K Warren; Robin L Carver; Deverick J Anderson; David P Calfee; Jason E Bowling; Nasia Safdar
Journal:  JAMA       Date:  2013-10-16       Impact factor: 56.272

8.  A comparison of hospital adverse events identified by three widely used detection methods.

Authors:  James M Naessens; Claudia R Campbell; Jeanne M Huddleston; Bjorn P Berg; John J Lefante; Arthur R Williams; Richard A Culbertson
Journal:  Int J Qual Health Care       Date:  2009-08       Impact factor: 2.038

9.  Safety of patients isolated for infection control.

Authors:  Henry Thomas Stelfox; David W Bates; Donald A Redelmeier
Journal:  JAMA       Date:  2003-10-08       Impact factor: 56.272

Review 10.  Adverse outcomes associated with Contact Precautions: a review of the literature.

Authors:  Daniel J Morgan; Daniel J Diekema; Kent Sepkowitz; Eli N Perencevich
Journal:  Am J Infect Control       Date:  2009-03       Impact factor: 2.918

View more
  8 in total

1.  Frequency of Adverse Events Before, During, and After Hospital Admission.

Authors:  Lindsay D Croft; Michael E Liquori; James Ladd; Hannah R Day; Lisa Pineles; Elizabeth M Lamos; Preeti Mehrotra; Eli N Perencevich; Anthony D Harris; Daniel J Morgan
Journal:  South Med J       Date:  2016-10       Impact factor: 0.954

2.  [Multidrug resistant bacteria in the intensive care unit : Reasonable measures for prevention].

Authors:  R Fussen; S Lemmen
Journal:  Med Klin Intensivmed Notfmed       Date:  2016-10-20       Impact factor: 0.840

3.  Elimination of Routine Contact Precautions for Endemic Methicillin-Resistant Staphylococcus aureus and Vancomycin-Resistant Enterococcus: A Retrospective Quasi-Experimental Study.

Authors:  Elise M Martin; Dana Russell; Zachary Rubin; Romney Humphries; Tristan R Grogan; David Elashoff; Daniel Z Uslan
Journal:  Infect Control Hosp Epidemiol       Date:  2016-07-26       Impact factor: 3.254

4.  Nonimpact of Decolonization as an Adjunctive Measure to Contact Precautions for the Control of Methicillin-Resistant Staphylococcus aureus Transmission in Acute Care.

Authors:  Lance R Peterson; Marc O Wright; Jennifer L Beaumont; Vanida Komutanon; Parul A Patel; Donna M Schora; Bryan H Schmitt; Ari Robicsek
Journal:  Antimicrob Agents Chemother       Date:  2015-10-12       Impact factor: 5.191

5.  Impact of isolation on hospitalised patients who are infectious: systematic review with meta-analysis.

Authors:  Edward Purssell; Dinah Gould; Jane Chudleigh
Journal:  BMJ Open       Date:  2020-02-18       Impact factor: 2.692

6.  Evaluation of Patients' Adverse Events During Contact Isolation for Vancomycin-Resistant Enterococci Using a Matched Cohort Study With Propensity Score.

Authors:  JaHyun Kang; Eunjeong Ji; Junghee Kim; Hyunok Bae; Eunyoung Cho; Eu Suk Kim; Myoung Jin Shin; Hong Bin Kim
Journal:  JAMA Netw Open       Date:  2022-03-01

7.  Variation in detected adverse events using trigger tools: A systematic review and meta-analysis.

Authors:  Luisa C Eggenschwiler; Anne W S Rutjes; Sarah N Musy; Dietmar Ausserhofer; Natascha M Nielen; René Schwendimann; Maria Unbeck; Michael Simon
Journal:  PLoS One       Date:  2022-09-01       Impact factor: 3.752

8.  Assessing the magnitude and trends in hospital acquired infections in Canadian hospitals through sequential point prevalence surveys.

Authors:  Geoffrey Taylor; Denise Gravel; Anne Matlow; Joanne Embree; Nicole LeSaux; Lynn Johnston; Kathryn N Suh; Michael John; John Embil; Elizabeth Henderson; Virginia Roth; Alice Wong
Journal:  Antimicrob Resist Infect Control       Date:  2016-05-21       Impact factor: 4.887

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.